Extrawell Pharmaceutical Holdings Limited (Extrawell Pharma) has signed an extension letter dated 29 May 2026 to move the Long Stop Date for the proposed fourth amendments to its bonds from 30 Jun 2026 to 30 Sep 2026. All other provisions in the Fourth Amendment Deed remain unchanged.

The extension follows the suspension of Starcoin’s shares on the Hong Kong Stock Exchange at 9:00 a.m. on 6 May 2026. The suspension was triggered by the Exchange’s determination that Starcoin failed to maintain the operational threshold required under Listing Rule 13.24. Given Starcoin’s status and the additional time needed to satisfy the conditions precedent, the parties involved agreed to the new Long Stop Date.

Consequently, dispatch of the shareholder circular—originally slated for on or before 30 May 2026—has been rescheduled. Extrawell Pharma now expects to send the document, which will detail the proposed bond amendments and the notice of a special general meeting, on or before 11 Sep 2026.

The board of Extrawell Pharma comprises five executive directors and three independent non-executive directors, with Chairman Xie Yi signing off on the announcement dated 29 May 2026.